Key result
Pulmonary embolism in lung cancer patients is linked to ~26% shorter survival vs. matched controls.
Why the study?
Cancer patients have a higher risk for thrombosis related to advanced stage and poor prognosis, but the clinical characteristics and outcomes of lung cancer patients with pulmonary embolism were not well defined.
Population
24 lung cancer patients with pulmonary embolism
Comparison
Lung cancer patients with PE vs matched controls without PE
Design
Case-control study
Authors
Loading...
PE in lung cancer patients was associated with shorter survival; leaves open whether targeted anticoagulation improves outcomes in this observational cohort.
Case-Control (n=24)
Absolute Event Rate: 243.5% vs 327%
p-value: p=0.01
Chuang et al. (2009) conducted a case-control in Lung cancer with pulmonary embolism (n=24). Pulmonary embolism vs. Matched controls was evaluated on Survival (days) (p=0.01). Pulmonary embolism in lung cancer patients was associated with significantly shorter survival compared to matched controls (243.5 vs. 327 days, p=0.01).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: